AbobotulinumtoxinA provides flexibility for the treatment of cervical dystonia with 500 U/1 mL and 500 U/2 mL dilutions

Mark F. Lew, Robert A. Hauser, Stuart H. Isaacson, Daniel Truong, Atul T. Patel, Allison Brashear, William Ondo, Pascal Maisonobe, Khashayar Dashtipour, Laxman Bahroo, Stefan Wietek

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Article number100115
JournalClinical Parkinsonism and Related Disorders
Volume5
DOIs
StatePublished - Jan 2021

ASJC Scopus Subject Areas

  • Clinical Neurology
  • Cellular and Molecular Neuroscience

Keywords

  • AbobotulinumtoxinA
  • Cervical dystonia
  • Dilution
  • Dosing flexibility
  • Treatment

Cite this